JPRN-UMIN000002236已完成未知
Intravenous liposomal amphotericin B versus intravenous voriconazole for chronic pulmonary aspergillosis: a multicenter, open-labeled trial in Japan - Comparison study between L-AMB and VRCZ for CPA
EOCI (Nagasaki Evaluation Organization for Clinical Interventions)0 个研究点目标入组 150 人开始时间: 2009年7月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The following patients are excluded from the study. #1. Patients who are going to be excluded due to the difficulty of determine efficacy. (1) patients received amphotericin B (AMPH-B), liposomal amphotericin B (L-AMB) or voriconazole (VRCZ) within a month at the time of the diagnosis of CPA, (2) patients received other antifungal drugs such as itraconazole, flucytosine, miconazole, fluconazole, nystatin or micafungin and have already started to being improved or with unknown medical course. (3) patients who are diagnosed other than CPA. #2. Patients who are going to be excluded due to the safety issues. (1) patients who fulfilled the contraindication of AMPH-B, L-AMB and VRCZ. (2) patients with liver, kidney and heart failure (more than Grade II in CTCAEv3.0). (3) pregnant or breast feeding patients, and patients who are willing to have baby. #3. Patients whom are considered to be excluded by the attending physicians with various reasons.
研究者
相似试验
进行中（未招募）
2 期
iposomal amphotericin B for the treatment of Bangladeshi patients with visceral leishmaniasis.ACTRN12609001029280The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35
已完成
2 期
iposomal amphotericin B for the treatment of Nepalese patients with visceral leishmaniasis.Visceral LeishmaniasisInfection - Other infectious diseasesACTRN12610000130066The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35
已完成
4 期
Comparison study of liposomal amphotericin B and micafungin in treatment of deep candidasis in surgical and emergency domainsInvasive CandidiasisJPRN-UMIN000006106Department of Infection Control and Prevention, Aichi Medical University Hospital100
招募中
不适用
Empirical treatment of liposomal amphotericin B for febrile neutropenia. that persists despite broad-spectrum antibacterial therapyfebrile neutropeniaJPRN-UMIN000005163The first department of internal medicine, University of Fukui50
已完成
2 期
Comparing efficacy of two treatment methods including topical liposomal Amphotericin B versus intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous LeishmaniasisCutaneous leishmaniasis.Cutaneous LeishmaniasisIRCT138802131871N1Research Council of Mashhad University of Medical Sciences110